Table 3.
Six lncRNAs Significantly Associated With OS of BC Patients in the Training Group
| Ensembl | Coefficienta | Exp(coef) | SE(Coef) | Z | Pr(>|Z|)b | |
|---|---|---|---|---|---|---|
| SNHG12 | ENSG00000197989 | −0.3012 | 0.7400 | 0.1725 | −1.7456 | 0.0809 |
| MAFG-AS1 | ENSG00000265688 | 0.3166 | 1.3724 | 0.1050 | 3.0156 | 0.0026 |
| LINC02321 | ENSG00000258884 | 0.1725 | 1.1883 | 0.0782 | 2.2072 | 0.0273 |
| ASMTL-AS1 | ENSG00000236017 | −0.1791 | 0.8360 | 0.1042 | −1.7192 | 0.0856 |
| LINC01322 | ENSG00000244128 | 0.1582 | 1.1714 | 0.0461 | 3.4279 | 0.0006 |
| LINC00922 | ENSG00000261742 | 0.1242 | 1.1322 | 0.0614 | 2.0245 | 0.0429 |
Notes: aDerived from univariate Cox proportional-hazard regression analysis in the 188 training-group patients. bObtained from permutation test repeated 10,000 times.
Abbreviations: BC, bladder cancer; OS, overall survival.